Topic

Texas

A collection of 504 issues

How to Get Pemazyre (pemigatinib) Covered by UnitedHealthcare in Texas: Appeals Guide & Templates

Answer Box: Getting Pemazyre Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Pemazyre (pemigatinib) with step therapy requirements. First step: Submit PA through the UnitedHealthcare Provider Portal with FGFR2/FGFR1 testing results, prior therapy documentation, and ophthalmologic monitoring plan. If denied, you have 180 days to file an

How to Handle Oxbryta (Voxelotor) Coverage Denial by Cigna in Texas: Appeals Guide After FDA Withdrawal

Answer Box: Oxbryta Coverage in Texas Oxbryta (voxelotor) was voluntarily withdrawn from the U.S. market in September 2024 due to safety concerns, making coverage appeals moot for new prescriptions. If you're currently taking Oxbryta, work with your hematologist immediately to transition to alternative sickle cell treatments like

Getting Abecma (Idecabtagene Vicleucel) Covered by Cigna in Texas: Complete Coverage Guide and Appeal Process

Answer Box: How to Get Abecma Covered by Cigna in Texas Abecma (idecabtagene vicleucel) requires Cigna prior authorization in Texas. Your fastest path to approval: 1) Confirm you meet FDA criteria (relapsed/refractory multiple myeloma after ≥2 prior lines including IMiD, proteasome inhibitor, and anti-CD38 antibody), 2) Have your oncologist

How to Get Onpattro (Patisiran) Covered by UnitedHealthcare in Texas: Complete Coding and Appeals Guide

Answer Box: Getting Onpattro Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Onpattro (patisiran) with strict medical necessity criteria including genetic confirmation of hATTR-PN, neurologist evaluation, and specific disease staging. Use ICD-10 code E85.1, HCPCS J0222, and ensure complete documentation before submission. If denied, Texas law guarantees

The Requirements Checklist to Get Orladeyo (berotralstat) Covered by UnitedHealthcare in Texas: Forms, Appeals, and Timeline

Answer Box: Getting Orladeyo Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Orladeyo (berotralstat) in Texas. The fastest path: (1) Confirm HAE diagnosis with C1-INH lab results, (2) Submit OptumRx PA form with complete clinical documentation, (3) Use electronic submission for 24-72 hour decisions. New users may face

How to Get Myozyme (Alglucosidase Alfa) Covered by Humana in Texas: Complete Guide to Forms, Appeals & Approval

Answer Box: Getting Myozyme Covered by Humana in Texas Fastest path to approval: Humana requires prior authorization for Myozyme (alglucosidase alfa) using HCPCS code J0221. Your doctor submits the request via Humana's provider portal, by fax to 877-486-2621, or by calling 800-555-CLIN (2546). Include confirmed Pompe disease diagnosis,

If Brensocatib (BRINSUPRI) Isn't Approved by Blue Cross Blue Shield in Texas: Formulary Alternatives & Exception Paths

Quick Answer: If Blue Cross Blue Shield Texas denies Brensocatib (BRINSUPRI), you have formulary alternatives like azithromycin and airway clearance therapy. File a formulary exception request with 72-hour decision timeline, or appeal denials through Texas's independent review process. Start by checking your specific plan's drug list

How to Get Cimzia (Certolizumab Pegol) Covered by Humana in Texas: Prior Authorization, Step Therapy & Appeals Guide

Quick Answer: Getting Cimzia Covered by Humana in Texas Cimzia (certolizumab pegol) requires prior authorization from Humana and is subject to step therapy requirements. Your fastest path to approval: 1) Have your doctor document failed trials of preferred anti-TNF biosimilars, 2) Submit a medical necessity letter with your PA request

Lowering Out-of-Pocket Costs for Bylvay (odevixibat) with UnitedHealthcare in Texas: Copay Assistance, Tiering Exceptions & Financial Aid

Quick Answer: Reducing Your Bylvay Costs in Texas Bylvay (odevixibat) costs $14,152-$44,562 monthly with UnitedHealthcare, but multiple cost-reduction strategies exist. Commercially insured patients can access IPSEN CARES copay assistance (potentially $0 copay), while Medicare/Medicaid patients need foundation grants. Key steps: 1) Apply for IPSEN CARES immediately,

Getting Somatuline Depot (Lanreotide) Covered by Cigna in Texas: Prior Authorization, Appeals, and Cost-Saving Strategies

Quick Answer: Cigna requires prior authorization for Somatuline Depot (lanreotide) with documentation of octreotide trial unless contraindicated. Your endocrinologist/oncologist must submit medical necessity forms within 72 hours for standard review. If denied, file internal appeal within 180 days, then external review through Texas IRO within 4 months. Commercial patients